Educational videos: Participants will be provided with four educational videos in clinic prior to their initial medical oncology consult.
Standard of Care: Participants in the control arm will be provided with the educational videos after their consult with the medical oncologist.
Study summary
This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment.
Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
1. Signed written and voluntary informed consent.
2. Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma.
3. Age ≥ 18 years.
4. Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma.
5. Willing/able to complete questionnaires.
6. Able to read and write in English.
Exclusion Criteria:
1. Inability to provide informed consent.
2. Previously seen by a medical oncologist for their sarcoma.
Primary outcome measure(s)
Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention — up to 2 weeks (date when given appointment and date of first appointment) Evaluate the changes in global responses between baseline surveys and post educational intervention surveys.
Trial sites (1)
Facility
City
Region
Status
Mount Sinai Hospital
Toronto
Ontario
Recruiting
More Mount Sinai Hospital, Canada trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.